PROM1 and hepatocellular carcinoma: Subsequent experiments confirmed that CD133 can serve as a robust marker for characterizing the HCC cell lines HepG2, Huh7, and PLC/PRF/5, which is consistent with previous findings [6,7,40,41,42].